Vermillion, Inc (Vrml) - Product Pipeline Analysis, Update 2014

Submitted by: Submitted by

Views: 51

Words: 694

Pages: 3

Category: Business and Industry

Date Submitted: 12/17/2014 12:36 AM

Report This Essay

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

Vermillion, Inc (VRML) - Product Pipeline Analysis, Update 2014

Summary

Vermillion, Inc. (Vermillion) is a healthcare service provider. The company develops and commercializes multi-marker, diagnostic tests, which addresses unmet needs in gynecologic oncology and womens health. It manufactures OVA1 product. Vermillion's research and development center develops and validates biomarkers and algorithms. The company collaborates with other academic institutions in oncology, cardiology and womens health. It partners with Johns Hopkins University School of Medicine, University of Kentucky, and Stanford University. The company offers its services to patients in various states in the country. Vermillion is headquartered in Austin, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

To Browse a Full Report with Toc: http://www.researchmoz.us/vermillion-inc-vrml-product-pipeline-analysis-2014-update-report.html

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Vermillion, Inc.

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date.

Reasons to Buy:

- Develop business...